Literature DB >> 20838887

Proline-rich cytokine from neurosecretory granules: a new natural substrate for dipeptidyl peptidase IV.

Alvard A Antonyan1, Svetlana G Sharoyan, Sona S Mardanyan, Armen A Galoyan.   

Abstract

A proline-rich cytokine from neurosecretory granules of bovine neurohypophysis, 15 amino acids containing PRP-1 (Ala-Gly-Ala-Pro-Glu-Pro-Ala-Glu-Pro-Ala-Gln-Pro-Gly-Val-Tyr), had been demonstrated as a unique regulator of activity of neurons, strong antibacterial agent, and mediator of the hypothalamus-neurohypophysis-bone marrow-thymus axis, which participates in hematopoietic stem cells differentiation. In the present work it was shown that this neuropeptide represents a new natural substrate for Dipeptidyl Peptidase IV (DPPIV). The time-dependent increase of primary amines quantity in the assay mixture of PRP-1 and DPPIV has been observed allowing to conclude, that DPPIV catalyses the enzymatic reaction of PRP-1 cleavage. The amount of primary amines in the assay mixtures was evaluated using o-phtaldialdehyde dye. The gel-filtration and paper electrophoresis analyses proved this conclusion. The catalytic parameters of catalyzed by DPPIV enzymatic reaction of PRP-1 cleavage were determined as: V(max) = 1.27 ± 0.11 nmol/min and K(m) = 0.38 ± 0.1 mM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20838887     DOI: 10.1007/s11064-010-0258-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

Review 1.  Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides.

Authors:  R Mentlein
Journal:  Regul Pept       Date:  1999-11-30

2.  Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion.

Authors:  A M Lambeir; C Durinx; P Proost; J Van Damme; S Scharpé; I De Meester
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

3.  Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.

Authors:  Svetlana Sharoyan; Alvard Antonyan; Sona Mardanyan; Giulio Lupidi; Gloria Cristalli
Journal:  Acta Biochim Pol       Date:  2006-08-21       Impact factor: 2.149

4.  A new hypothalamic polypeptide is a regulator of myelopoiesis.

Authors:  Armen A Galoyan; Vardan S Aprikyan
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

5.  Hypothalamic proline-rich polypeptide enhances bone marrow colony-forming cell proliferation and stromal progenitor cell differentiation.

Authors:  A A Galoyan; L I Korochkin; E J Rybalkina; G V Pavlova; I N Saburina; E I Zaraiski; N A Galoyan; T K Davtyan; K B Bezirganyan; A V Revishchin
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

6.  Hypothalamic proline-rich polypeptide protects brain neurons in aluminum neurotoxicosis.

Authors:  A A Galoyan; V A Shakhlamov; M I Aghajanov; H G Vahradyan
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

7.  Myc-oncogene inactivating effect by proline rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.

Authors:  Karina Galoian; Sean Scully; Armen Galoyan
Journal:  Neurochem Res       Date:  2008-07-09       Impact factor: 3.996

Review 8.  Proline residues in the maturation and degradation of peptide hormones and neuropeptides.

Authors:  R Mentlein
Journal:  FEBS Lett       Date:  1988-07-18       Impact factor: 4.124

Review 9.  Proline-dependent structural and biological properties of peptides and proteins.

Authors:  A Yaron; F Naider
Journal:  Crit Rev Biochem Mol Biol       Date:  1993       Impact factor: 8.250

10.  O-phthalaldehyde: fluorogenic detection of primary amines in the picomole range. Comparison with fluorescamine and ninhydrin.

Authors:  J R Benson; P E Hare
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

View more
  1 in total

1.  Morpho‑functional study of the hypothalamic proline‑rich polypeptide apoptotic activity against mouse Ehrlich ascites carcinoma.

Authors:  S Abrahamyan; I Sahakyan; N Tumasyan; N Kocharyan; A Simonyan; R Aroutiounian; G Chailyan; S Chailyan; T Davtyan; K Galoian
Journal:  Oncol Rep       Date:  2020-05-04       Impact factor: 3.906

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.